Related Experiment Videos
Cell proliferation studies in primary synovial chondromatosis
R I Davis1, H Foster, K Arthur
1Department of Pathology, Belfast City Hospital, Northern Ireland, U.K.
The Journal of Pathology
|May 16, 1998
Summary
Primary synovial chondromatosis (PSC) may not be simple metaplasia. DNA image cytometry suggests a proliferative component in PSC, intermediate between benign enchondromas and malignant chondrosarcomas.
Area of Science:
- Orthopedics
- Surgical Pathology
- Oncology
Background:
- Primary synovial chondromatosis (PSC) is traditionally viewed as cartilaginous metaplasia.
- However, its potential for local recurrence and malignant transformation suggests a proliferative component.
- Histological features like cellularity and binucleate forms hint at a non-metaplastic nature.
Purpose of the Study:
- To assess the proliferative activity in primary synovial chondromatosis (PSC).
- To compare the proliferative activity of PSC with enchondromas, chondrosarcomas, and normal articular cartilage.
- To investigate the potential for malignant transformation in PSC.
Main Methods:
- Immunohistochemical detection of Ki-67 protein.
- DNA image cytometry (VIDAS image analysis system).
- Comparative analysis of 20 PSC cases against 10 enchondromas, 10 chondrosarcomas, and 10 normal cartilage samples.
Main Results:
- No detectable Ki-67 staining in PSC or benign tissues; significant association between Ki-67 and grade in chondrosarcomas.
- Enchondromas showed diploid DNA histograms; 40% of PSC cases exhibited non-diploid histograms (hyperdiploid and aneuploid cells).
- PSC demonstrated significantly higher mean DNA content and aneuploidy than enchondromas, indicating a proliferative process.
Conclusions:
- The absence of Ki-67 in PSC supports a metaplastic origin, but DNA image cytometry suggests a proliferative process in some cases.
- PSC exhibits proliferative activity intermediate between benign enchondromas and malignant chondrosarcomas.
- This intermediate proliferative status may explain the occasional aggressive clinical behavior of PSC.